Prostate Cancer Reports


Volume 3 Supplement 2
Febryary 2015

Home > Prostate Cancer Reports > Volume 3, Year 2015 > Supplement 2, February


CONTENTS


Volume 3 Supplement 2
Febryary 2015

Case reports
Detection, diagnosis and evaluation
Integrative medicine
Overall management
Prognosis and outcome



CASE REPORTS



Acosta-Gonzalez G, Qin J, Wieczorek R, Melamed J, Deng FM, Zhou M, Makarov D, Ye F, Pei Z, Pincus MR, Lee P.
De novo large cell neuroendocrine carcinoma of the prostate, case report and literature review.
Am J Clin Exp Urol. 2014 Dec 25;2(4):337-42. eCollection 2014.
Abstract | Full text | Related citations

DETECTION, DIAGNOSIS AND EVALUATION



Giovacchini G, Incerti E, Mapelli P, Kirienko M, Briganti A, Gandaglia G, Montorsi F, Gianolli L, Picchio M.
[¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.
Eur J Nucl Med Mol Imaging. 2015 May;42(6):877-84. doi: 10.1007/s00259-015-3015-8. Epub 2015 Feb 20.
Abstract | Related citations


Paparo F, Piccardo A, Bacigalupo L, Romagnoli A, Piccazzo R, Monticone M, Cevasco L, Campodonico F, Conzi GM, Carmignani G, Rollandi GA.
Value of bimodal 18F-choline-PET/MRI and trimodal 18F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy.
Abdom Imaging. 2015 Jan 13. [Epub ahead of print]
Abstract | Related citations

INTEGRATIVE MEDICINE



Hevia D, González-Menéndez P, Quiros-González I, Miar A, Rodríguez-García A, Tan DX, Reiter RJ, Mayo JC, Sainz RM.
Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer.
J Pineal Res. 2015 Mar;58(2):234-50. doi: 10.1111/jpi.12210. Epub 2015 Feb 7.
Abstract | Related citations


Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J.
Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies.
Cancer Treat Rev. 2015 Apr 11. pii: S0305-7372(15)00074-2. doi: 10.1016/j.ctrv.2015.04.005. [Epub ahead of print]
Abstract | Related citations

OVERALL MANAGEMENT



Parimi V, Goyal R, Poropatich K, Yang XJ.
Neuroendocrine differentiation of prostate cancer: a review.
Am J Clin Exp Urol. 2014 Dec 9;2(4):273-85. eCollection 2014.
Abstract | Full text | Related citations

PROGNOSIS AND OUTCOME



Hegarty SE, Hyslop T, Dicker AP, Showalter TN.
Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.
PLoS One. 2015 Feb 23;10(2):e0118430. doi: 10.1371/journal.pone.0118430. eCollection 2015.
Abstract | Full text | Related citations


Mandel P, Steuber T, Ahyai S, Kriegmair M, Schiffmann J, Boehm K, Heinzer H, Michl U, Schlomm T, Haese A, Huland H, Graefen M, Tilki D.
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
BJU Int. 2015 Feb 24. doi: 10.1111/bju.13103. [Epub ahead of print]
Abstract | Related citations


Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS.
Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
J Urol. 2015 Feb 21. pii: S0022-5347(15)00394-8. doi: 10.1016/j.juro.2015.02.084. [Epub ahead of print]
Abstract | Related citations